Aurora Cannabis Inc. (ACB) vs Alpha Teknova, Inc. (TKNO)

Aurora Cannabis Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $486.2M against $341.2M — 1.4× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 15.5% against −18.2%. Alpha Teknova, Inc. has the higher net margin (−34.8% vs −38.1%) and the lower return on invested capital (−16.6% vs −5.58%). Across the 18 metrics below, Aurora Cannabis Inc. leads on 10 and Alpha Teknova, Inc. on 8.

Valuation

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 9.15 2.08
P/B 0.84 7.03 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.28 9.17 2.87
Earnings yield (27.12%) (3.70%) (15.94%)
Free cash flow yield (11.26%) (1.52%) 0.00%

Profitability

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 36.43% 53.51%
Operating margin (12.13%) (32.65%) 0.00%
Net margin (38.12%) (34.76%) (2.45%)
Free cash flow margin (17.19%) (13.89%) 0.00%
Return on equity (19.85%) (24.12%) (0.80%)
Return on assets (15.19%) (15.79%) (1.67%)
Return on invested capital (5.58%) (16.60%) 0.00%

Growth

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 15.45% 5.22%
EPS growth (last fiscal year) (5,266.67%) 43.86% 42.91%
Revenue growth, 5-year CAGR 3.92% 5.30% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.22 0.04
Current ratio 5.36 3.56 2.41
Net debt to EBITDA 5.11 0.75 1.01

Dividend

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Market cap 341.19m 486.22m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack